Ösophagitis unter Immunsuppression

Translated title of the contribution: Esophagitis during immunosuppression

F. Moosig*, W. L. Gross

*Corresponding author for this work
1 Citation (Scopus)

Abstract

Esophagitis due to cytomegalovirus (CMV) has mostly been described in patients with acquired immunodeficiency syndrome (AIDS). Distal and hemorrhagic ulcerations are characteristic. A CMA esophagitis can, however, also occur in patients with no human immunodeficiency virus (HIV) infection as a complication of immunosuppressive therapy. In the case example presented here the disease was due to an excessive dosage of prednisolone medication over a period of many years. In all published cases of CMV esophagitis with rheumatic diseases, there was also a high dosage of glucocorticoid medication. To avoid complications regular rheumatological screening controls and adjustment of immunosuppressive therapy are therefore important to maintain control of the disease with low dosage glucocorticoids.

Translated title of the contributionEsophagitis during immunosuppression
Original languageGerman
JournalZeitschrift fur Rheumatologie
Volume71
Issue number4
Pages (from-to)326-327
Number of pages2
ISSN0340-1855
DOIs
Publication statusPublished - 06.2012

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Esophagitis during immunosuppression'. Together they form a unique fingerprint.

Cite this